A股異動丨華東醫藥(000963.SZ)逼近漲停 醫美產品獲得醫療器械註冊證
格隆匯4月14日丨華東醫藥(000963.SZ)高開高走,盤初一度觸及漲停價,現漲9.49%,報38.32元,總市值670億元。華東醫藥昨晚發佈公吿稱,公司英國全資子公司Sinclair醫美產品Ellansé® 獲國家藥監局《醫療器械註冊證》。本次獲批的產品型號為 Ellansé-S,適用範圍用於皮下層植入,以糾正中到重度鼻脣溝皺紋。Ellansé®目前已在60多個國家或地區獲得註冊認證或上市准入。此次華東醫藥獲得Ellansé®中國大陸醫療器械註冊證,不僅豐富和完善了公司非手術類醫美產品管線,也是公司醫美業務“全球化運營佈局,雙循環經營發展”戰略的重大里程碑,預計將於2021年下半年在中國大陸正式上市銷售。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.